Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

Bibliographic Details
Main Authors:	Ishwarlal Jialal, Naval Vikram
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-09-01
Series:	Therapeutic Advances in Cardiovascular Disease
Online Access:	https://doi.org/10.1177/17539447211042714

Similar Items

Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
by: Ishwarlal Jialal, et al.
Published: (2023-05-01)

Is colchicine the holy grail for treating inflammation and reducing cardiovascular risk?
by: Krzysztof J. Filipiak, et al.
Published: (2021-09-01)

Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events
by: Kevin E. Boczar, MD, et al.
Published: (2023-05-01)

Both the platelet count and the platelet: lymphocyte ratio are not increased in nascent metabolic syndrome
by: Ganesh Jialal, et al.
Published: (2019-11-01)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
by: Ishwarlal Jialal, et al.
Published: (2019-10-01)

Fetuin-A is also an adipokine
by: Ishwarlal Jialal, et al.
Published: (2019-03-01)

Mechanosensitive Stem-Cell Genes and Klotho in Atherosclerotic Aortas: Regulating Spatially Deranged Expression Patterns Using Colchicine Regimens
by: Konstantinos S. Mylonas, et al.
Published: (2022-10-01)

Correlates of Insulin Resistance in Nascent Metabolic Syndrome
by: Beverley Adams-Huet, et al.
Published: (2023-04-01)

Colchicine in cardiovascular diseases
by: Narra Lavanya, et al.
Published: (2023-01-01)

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
by: Boghuma Titanji, et al.
Published: (2020-02-01)

Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation
by: Ulrike Meyer-Lindemann, et al.
Published: (2022-07-01)

Biomechanics and inflammation in atherosclerotic plaque erosion and plaque rupture: implications for cardiovascular events in women.
by: Ian C Campbell, et al.
Published: (2014-01-01)

Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome
by: Ishwarlal Jialal, et al.
Published: (2023-06-01)

Colchicine in acute myocardial infarction: cardiovascular events at 1-year follow up
by: François Roubille, et al.
Published: (2024-01-01)

COLCHICINE IS ASSOCIATED WITH LOWER CARDIOVASCULAR MORBIDITY IN GOUT
by: Claudiu Popescu, et al.
Published: (2016-12-01)

Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)
by: Dominik M. Schulte, et al.
Published: (2022-06-01)

Optimization of Medication Regimens in Patients with Type 2 Diabetes and Clinical Atherosclerotic Cardiovascular Disease
by: Jarred Prudencio, et al.
Published: (2021-11-01)

Inflammation, atrial fibrillation, and the potential role for colchicine therapy
by: Bibin Varghese, MD, et al.
Published: (2021-06-01)

The relationship between Type D personality with atherosclerotic plaque and cardiovascular events: The mediation effect of inflammation and kynurenine/tryptophan metabolism
by: Yini Wang, et al.
Published: (2022-10-01)

NEW POSSIBILITIES IN THE TREATMENT OF CARDIOVASCULAR DISEASE USING COLCHICINE
by: M. T. Vatutin, et al.
Published: (2016-06-01)

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
by: Justine Cole, et al.
Published: (2023-09-01)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
by: Anne Mirjam Kerola, et al.
Published: (2021-05-01)

The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells
by: Mohan R. Dasu, et al.
Published: (2007-03-01)

Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways
by: Ping Wang, et al.
Published: (2019-05-01)

Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study
by: Wende Tian, et al.
Published: (2022-09-01)

Inflammation in atherosclerotic cardiovascular disease [version 1; peer review: 4 approved]
by: Prediman K. Shah, et al.
Published: (2019-08-01)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
by: Vignesh Chidambaram, et al.
Published: (2021-07-01)

Schamberg's disease: case report with therapeutic success by using colchicine
by: Maria Lopes Lamenha Lins Cavalcante, et al.
Published: (2017-03-01)

High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth—Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen
by: Richard E. Kast
Published: (2022-10-01)

Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain
by: Icíar Martínez López, et al.
Published: (2024-02-01)

Colchicine for pericarditis.
by: Alabed, S, et al.
Published: (2014)

Colchicine for gout
by: M. S. Eliseev, et al.
Published: (2021-08-01)

Colchicine Toxicity
by: Vinaya Mulkareddy, MD, et al.
Published: (2020-04-01)

Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation
by: Sofija I. Lugonja, et al.
Published: (2023-03-01)

Harnessing the Therapeutic Potential of Decoys in Non-Atherosclerotic Cardiovascular Diseases: State of the Art
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

Bempedoic acid: mechanism of action and therapeutic use in atherosclerotic cardiovascular diseases and diabetes
by: V.A. Serhiyenko, et al.
Published: (2023-05-01)

Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization
by: Camila Stuchi Zarpelon, et al.
Published: (2016-01-01)

Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? [version 1; referees: 2 approved]
by: Yanglu Zhao, et al.
Published: (2015-10-01)

Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury
by: Fei Sun, et al.
Published: (2024-01-01)

Acute pancreatitis related to therapeutic dosing with colchicine: a case report
by: Ting Joseph
Published: (2007-08-01)